News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 17, 2017

Carolyn: Journey Through Treatment

Newsletter

Stay up to date on cancer updates, research and education

Related Content

breast cancer

HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

ByAndrea Eleazar, MHS

October 19th 2025

breast cancer

Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer

October 19th 2025

breast cancer

Enhertu Reduces Risk of Invasive Disease or Death in HER2+ Breast Cancer

ByAshling Wahner

October 18th 2025

breast cancer

Giredestrant/Afinitor Reduces Progression in Advanced Breast Cancer

October 18th 2025

Image of woman.

Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer

October 17th 2025

Trending on CURE

Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer

HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

Imdelltra Improves Survival For Some With Small Cell Lung Cancer

Trodelvy in Metastatic Triple-Negative Breast Cancer Supported by Phase 3 Trial

© 2025 MJH Life Sciences^®

All rights reserved.